Recent Company News

• 06:33 PM ET Oct 30, 2025
  

  Alterity Therapeutics reports Q1 net cash from / (used in) operating activities (A$5.3M) - Appendix 4C (A$0.01, 0.00)

• 09:43 PM ET Sep 14, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 08:14 AM ET Oct 09, 2025
  

  Alterity Therapeutics presents data from ATH434 Phase 2 trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders (A$0.01, 0.00)

• 06:40 PM ET Oct 01, 2025
  

  Alterity Therapeutics to present data from the ATH434-201 Phase 2 trial in multiple system atrophy at MDS 2025 (A$0.01, 0.00)

• 09:55 PM ET Sep 25, 2025
  

  StreetAccount Summary - Australia unusual volume traders